News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KANGO SUJAY
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| KANGO SUJAY (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 90,000 options to buy
@ $1.13, valued at
$101.7k
|
|
| 03/31/2022 |
3
| KANGO SUJAY (Director) has filed a Form 3 on INFINITY PHARMACEUTICALS, INC. |
| 11/23/2021 |
4
| KANGO SUJAY (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 58,334 options to buy
@ $2.69, valued at
$156.9k
|
|
| 11/23/2021 |
3
| KANGO SUJAY (Director) has filed a Form 3 on MEI Pharma, Inc. |
| 11/22/2021 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 18,509 shares
@ $0
Disposed/sold 25,000 options to buy
@ $40.61, valued at
$1M
Disposed/sold 25,500 options to buy
@ $41.64, valued at
$1.1M
Disposed/sold 24,334 options to buy
@ $52.99, valued at
$1.3M
Disposed/sold 20,896 options to buy
@ $115.53, valued at
$2.4M
|
|
| 09/27/2021 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 5,000 shares
@ $175, valued at
$875k
Exercised 5,000 options to buy
@ $40.61, valued at
$203.1k
|
|
| 09/22/2021 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 5,000 shares
@ $150.03, valued at
$750.2k
Exercised 5,000 options to buy
@ $40.61, valued at
$203.1k
|
|
| 06/08/2021 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Paid exercise price by delivering 887 shares
@ $130.87, valued at
$116.1k
|
|
| 03/04/2021 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 2,699 shares
@ $135.48, valued at
$365.7k
Sold 1,501 shares
@ $136.24, valued at
$204.5k
Sold 600 shares
@ $137.12, valued at
$82.3k
Sold 200 shares
@ $138.15, valued at
$27.6k
Exercised 5,000 options to buy
@ $40.61, valued at
$203.1k
|
|
| 02/02/2021 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 5,409 shares
@ $0
Granted 20,896 options to buy
@ $115.53, valued at
$2.4M
|
|
| 02/02/2021 |
4/A
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Exercised 10,000 options to buy
@ $40.61, valued at
$406.1k
|
|
| 01/06/2021 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Paid exercise price by delivering 1,357 shares
@ $124.31, valued at
$168.7k
Sold 1,947 shares
@ $123.9, valued at
$241.2k
Sold 3,429 shares
@ $125.17, valued at
$429.2k
Sold 4,624 shares
@ $126.15, valued at
$583.3k
|
|
| 02/14/2020 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 590 shares
@ $94.09, valued at
$55.5k
Sold 5 shares
@ $94.82, valued at
$474.1 |
|
| 01/24/2020 |
4
| KANGO SUJAY (SVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 6,369 shares
@ $0
Granted 24,334 options to buy
@ $52.99, valued at
$1.3M
|
|
| 01/03/2020 |
4
| KANGO SUJAY (SVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 469 shares
@ $51.37, valued at
$24.1k
Sold 11 shares
@ $51.27, valued at
$564 |
|
| 01/29/2019 |
4
| KANGO SUJAY (SVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 4,050 shares
@ $0
Granted 25,500 options to buy
@ $41.64, valued at
$1.1M
|
|
| 03/05/2018 |
4
| KANGO SUJAY (SVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $40.61, valued at
$2M
|
|
| 02/13/2018 |
4
| KANGO SUJAY (SVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 6,000 shares
@ $0 |
|
| 02/13/2018 |
3
| KANGO SUJAY (SVP, Chief Commercial Officer) has filed a Form 3 on ACCELERON PHARMA INC |
| 12/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/02/2016 |
4
| KANGO SUJAY (Chief Commercial Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 01/08/2016 |
4
| KANGO SUJAY (Chief Commercial Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 60,000 options to buy
@ $6.71, valued at
$402.6k
|
|
| 04/01/2015 |
4
| KANGO SUJAY (Chief Commercial Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 200,000 options to buy
@ $13.98, valued at
$2.8M
|
|
| 04/12/2006 |
5
| KANGO SUJAY (CEO) has filed a Form 5 on INNOVATE ONCOLOGY, INC. |
|
|